224 related articles for article (PubMed ID: 30183122)
1. Vaso-occlusive crisis as a predictor of symptomatic avascular necrosis in children with sickle cell disease.
Mesleh Shayeb A; Smeltzer MP; Kaste SC; Brown A; Estepp JH; Nottage KA
Pediatr Blood Cancer; 2018 Dec; 65(12):e27435. PubMed ID: 30183122
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.
Yu T; Campbell T; Ciuffetelli I; Haywood C; Carroll CP; Resar L; Strouse JJ; Lanzkron S
South Med J; 2016 Sep; 109(9):519-24. PubMed ID: 27598353
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and impact of orthopaedic monitoring on the outcome of avascular necrosis of the femoral head in adults with sickle cell disease: 215 patients case study with control group.
Mukisi-Mukaza M; Saint Martin C; Etienne-Julan M; Donkerwolcke M; Burny ME; Burny F
Orthop Traumatol Surg Res; 2011 Dec; 97(8):814-20. PubMed ID: 22079613
[TBL] [Abstract][Full Text] [Related]
4. Avascular necrosis in sickle cell (homozygous S) patients: predictive clinical and laboratory indices.
Madu AJ; Madu AK; Umar GK; Ibekwe K; Duru A; Ugwu AO
Niger J Clin Pract; 2014; 17(1):86-9. PubMed ID: 24326814
[TBL] [Abstract][Full Text] [Related]
5. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.
Adekile AD; Gupta R; Yacoub F; Sinan T; Al-Bloushi M; Haider MZ
Acta Haematol; 2001; 105(1):27-31. PubMed ID: 11340250
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
7. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
Kord Valeshabad A; Wanek J; Gaynes B; Saraf SL; Molokie R; Shahidi M
Clin Hemorheol Microcirc; 2015 Sep; 62(4):359-67. PubMed ID: 26444608
[TBL] [Abstract][Full Text] [Related]
9. The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease.
Kutlar A; Kutlar F; Turker I; Tural C
Hemoglobin; 2001 May; 25(2):213-7. PubMed ID: 11480782
[TBL] [Abstract][Full Text] [Related]
10. Characterization of opioid use in sickle cell disease.
Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for osteonecrosis of the femoral head in five hundred and ten sickle cell disease paediatric patients.
Int Orthop; ; . PubMed ID: 37452863
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
